nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—IL6-mediated signaling events—PTPRE—bile duct cancer	0.198	0.313	CbGpPWpGaD
Rifabutin—HSP90B1—gall bladder—bile duct cancer	0.104	0.282	CbGeAlD
Rifabutin—HSP90AA1—gall bladder—bile duct cancer	0.0759	0.206	CbGeAlD
Rifabutin—HSP90B1—pancreas—bile duct cancer	0.0478	0.13	CbGeAlD
Rifabutin—HSP90AA1—pancreas—bile duct cancer	0.035	0.095	CbGeAlD
Rifabutin—HSP90B1—liver—bile duct cancer	0.0304	0.0827	CbGeAlD
Rifabutin—HSP90B1—lymph node—bile duct cancer	0.0233	0.0634	CbGeAlD
Rifabutin—HSP90AA1—liver—bile duct cancer	0.0222	0.0605	CbGeAlD
Rifabutin—HSP90AA1—ErbB receptor signaling network—ERBB2—bile duct cancer	0.0173	0.0273	CbGpPWpGaD
Rifabutin—HSP90AA1—lymph node—bile duct cancer	0.0171	0.0464	CbGeAlD
Rifabutin—HSP90AA1—LKB1 signaling events—SMAD4—bile duct cancer	0.0133	0.021	CbGpPWpGaD
Rifabutin—HSP90AA1—ErbB receptor signaling network—EGFR—bile duct cancer	0.012	0.0189	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—NRAS—bile duct cancer	0.0109	0.0172	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—MUC1—bile duct cancer	0.0104	0.0164	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—MUC4—bile duct cancer	0.0104	0.0164	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—TGFBR2—bile duct cancer	0.0103	0.0164	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—EGFR—bile duct cancer	0.0099	0.0157	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—ROBO2—bile duct cancer	0.00947	0.015	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—IL6—bile duct cancer	0.00945	0.0149	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—KRAS—bile duct cancer	0.00936	0.0148	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—bile duct cancer	0.00832	0.0132	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.00816	0.0129	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—HRAS—bile duct cancer	0.00795	0.0126	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—MUC2—bile duct cancer	0.00787	0.0125	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.00737	0.0117	CbGpPWpGaD
Rifabutin—CYP1A2—liver—bile duct cancer	0.00719	0.0195	CbGeAlD
Rifabutin—HSP90AA1—Semaphorin interactions—MET—bile duct cancer	0.00713	0.0113	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00689	0.0109	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ROBO2—bile duct cancer	0.00676	0.0107	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—SLC5A5—bile duct cancer	0.00655	0.0104	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—NRAS—bile duct cancer	0.00545	0.00863	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00536	0.00848	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFBR2—bile duct cancer	0.00528	0.00835	CbGpPWpGaD
Rifabutin—HSP90AA1—Semaphorin interactions—ERBB2—bile duct cancer	0.00521	0.00825	CbGpPWpGaD
Rifabutin—CYP3A4—liver—bile duct cancer	0.00521	0.0141	CbGeAlD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00498	0.00788	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00488	0.00772	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00488	0.00772	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—HGF—bile duct cancer	0.00485	0.00767	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—KRAS—bile duct cancer	0.00469	0.00743	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00461	0.0073	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP2—bile duct cancer	0.00454	0.00718	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—bile duct cancer	0.00433	0.00684	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—HRAS—bile duct cancer	0.00399	0.00631	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—IL6—bile duct cancer	0.00392	0.00621	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00392	0.0062	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—bile duct cancer	0.00392	0.0062	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—TGFB1—bile duct cancer	0.00364	0.00576	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00362	0.00572	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—bile duct cancer	0.00357	0.00565	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—FAR2—bile duct cancer	0.00355	0.00561	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP9—bile duct cancer	0.00341	0.0054	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.00308	0.00487	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.00286	0.00452	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.00273	0.00431	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00266	0.00421	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.00265	0.00419	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.00258	0.00408	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—NRAS—bile duct cancer	0.00257	0.00407	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—ERBB2—bile duct cancer	0.00256	0.00405	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HGF—bile duct cancer	0.00241	0.00381	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—ERBB2—bile duct cancer	0.00239	0.00377	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—MMP2—bile duct cancer	0.00238	0.00376	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.00236	0.00374	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—bile duct cancer	0.00235	0.00372	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.00235	0.00371	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.00225	0.00356	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—KRAS—bile duct cancer	0.00222	0.00351	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—bile duct cancer	0.00221	0.0035	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.00215	0.00341	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RNF43—bile duct cancer	0.00207	0.00327	CbGpPWpGaD
Rifabutin—HSP90AA1—Influenza Infection—TGFB1—bile duct cancer	0.00203	0.00321	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MET—bile duct cancer	0.00202	0.0032	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.002	0.00316	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB1—bile duct cancer	0.00198	0.00313	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—NRAS—bile duct cancer	0.00195	0.00308	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.00191	0.00302	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SMAD4—bile duct cancer	0.00188	0.00298	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—bile duct cancer	0.00188	0.00298	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NRAS—bile duct cancer	0.00181	0.00287	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—bile duct cancer	0.0018	0.00285	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—NRAS—bile duct cancer	0.00179	0.00283	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IDH1—bile duct cancer	0.00178	0.00281	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—bile duct cancer	0.00177	0.00281	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—IDH2—bile duct cancer	0.00173	0.00274	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP2—bile duct cancer	0.00169	0.00267	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—KRAS—bile duct cancer	0.00168	0.00265	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00168	0.00265	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—bile duct cancer	0.00165	0.00262	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—bile duct cancer	0.00163	0.00258	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—KRAS—bile duct cancer	0.00156	0.00247	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KRAS—bile duct cancer	0.00154	0.00244	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—IDH1—bile duct cancer	0.00149	0.00236	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—bile duct cancer	0.00148	0.00234	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00145	0.00229	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RNF43—bile duct cancer	0.00145	0.00229	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MET—bile duct cancer	0.00144	0.00228	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—bile duct cancer	0.00142	0.00225	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERBB2—bile duct cancer	0.00139	0.0022	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—bile duct cancer	0.00136	0.00216	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00136	0.00214	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—bile duct cancer	0.00133	0.0021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—bile duct cancer	0.00131	0.00207	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—bile duct cancer	0.00127	0.00201	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—bile duct cancer	0.00127	0.002	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—bile duct cancer	0.00125	0.00198	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP2—bile duct cancer	0.0012	0.0019	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00113	0.00178	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—bile duct cancer	0.00112	0.00178	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NRAS—bile duct cancer	0.00106	0.00167	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—bile duct cancer	0.00105	0.00167	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00105	0.00166	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00103	0.00162	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00103	0.00162	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—bile duct cancer	0.00102	0.00162	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—bile duct cancer	0.00101	0.0016	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC5A5—bile duct cancer	0.000983	0.00155	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00097	0.00153	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—bile duct cancer	0.000967	0.00153	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—bile duct cancer	0.000963	0.00152	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFBR2—bile duct cancer	0.000945	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HGF—bile duct cancer	0.000941	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—bile duct cancer	0.000931	0.00147	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—bile duct cancer	0.000927	0.00147	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—bile duct cancer	0.00091	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—bile duct cancer	0.000904	0.00143	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SMAD4—bile duct cancer	0.000895	0.00142	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000825	0.0013	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—bile duct cancer	0.000822	0.0013	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—bile duct cancer	0.000802	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—bile duct cancer	0.000787	0.00125	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—bile duct cancer	0.000773	0.00122	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GNAS—bile duct cancer	0.000764	0.00121	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FAR2—bile duct cancer	0.000746	0.00118	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—bile duct cancer	0.000745	0.00118	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—bile duct cancer	0.00074	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—bile duct cancer	0.000731	0.00116	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—bile duct cancer	0.000708	0.00112	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000703	0.00111	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—bile duct cancer	0.00069	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—bile duct cancer	0.000666	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFBR2—bile duct cancer	0.000662	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—bile duct cancer	0.000645	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GNAS—bile duct cancer	0.000638	0.00101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMAD4—bile duct cancer	0.000626	0.000991	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—bile duct cancer	0.00061	0.000965	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—bile duct cancer	0.000587	0.000928	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000576	0.000911	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—bile duct cancer	0.000568	0.000899	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—bile duct cancer	0.000562	0.000889	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—bile duct cancer	0.000542	0.000858	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—bile duct cancer	0.000518	0.00082	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—bile duct cancer	0.000501	0.000792	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—bile duct cancer	0.000496	0.000785	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—bile duct cancer	0.00049	0.000775	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—bile duct cancer	0.000413	0.000653	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—bile duct cancer	0.00041	0.000649	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—bile duct cancer	0.000381	0.000603	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—bile duct cancer	0.000376	0.000595	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000364	0.000576	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—bile duct cancer	0.000355	0.000562	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—bile duct cancer	0.000354	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—bile duct cancer	0.000351	0.000555	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—bile duct cancer	0.000347	0.000549	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—bile duct cancer	0.000328	0.000519	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000313	0.000496	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—bile duct cancer	0.000302	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—bile duct cancer	0.000301	0.000476	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—bile duct cancer	0.000289	0.000457	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000281	0.000445	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—bile duct cancer	0.000279	0.000441	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—bile duct cancer	0.000267	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—bile duct cancer	0.000267	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—bile duct cancer	0.000248	0.000392	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—bile duct cancer	0.000243	0.000384	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000242	0.000382	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—bile duct cancer	0.00023	0.000363	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000207	0.000327	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—bile duct cancer	0.000204	0.000323	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—bile duct cancer	0.000195	0.000309	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000194	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—bile duct cancer	0.000187	0.000295	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GNAS—bile duct cancer	0.000161	0.000254	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.00016	0.000252	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000124	0.000196	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—bile duct cancer	8.62e-05	0.000136	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—bile duct cancer	6.66e-05	0.000105	CbGpPWpGaD
